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LETTERS
Vibrio cholerae 
O1 Hybrid El Tor 
Strains, Asia 
and Africa
To the Editor: Vibrio cholerae is 
a water-borne pathogen that causes a 
severe watery diarrhea disease known 
as cholera. On the basis of variable 
somatic O antigen composition, >200 
serogroups of V. cholerae have been 
recognized. Classical and El Tor are 
2 well-established biotypes within the 
V. cholerae O1 serogroup, and they 
can be distinguished by differences 
in their biochemical reactions or phe-
notypic traits (1). In addition to phe-
notypic traits, genetic markers have 
recently been used in the identiﬁ  ca-
tion of the biotypes of V. cholerae. For 
example, the major toxin-coregulated 
pilus (TCP) gene, tcpA, of the TCP 
cluster possesses classical- and El 
Tor–speciﬁ  c alleles that encode identi-
cal functions but differ in their DNA 
sequence composition; however, the 
rtxC gene of the repeat in toxin (RTX) 
cluster is present in El Tor strains only 
and absent in classical strains (2,3). 
The cholera toxin, encoded by the 
ctxA and ctxB genes, is the principal 
toxin produced by V. cholerae O1 and 
O139 and is responsible for the disease 
cholera. Heterogeneity within the ctxB 
gene and protein was ﬁ  rst reported in 
the early 1990s, and, on this basis, 3 
ctxB genotypes of the V. cholerae O1 
strains have been identiﬁ  ed. Based on 
amino acid residue substitutions at 
positions 39, 46, and 68, all classical 
and US Gulf Coast El Tor strains have 
been categorized as genotype 1, the 
Australian El Tor strains as genotype 
2, and the El Tor strains of the seventh 
pandemic and the Latin American epi-
demic as genotype 3. Genotyping of 
ctxB has indicated that the classical 
strains harbor a unique cholera toxin 
gene that is not in the El Tor strains ex-
cept for the US Gulf Coast El Tor clone 
(4). The US Gulf Coast hybrid El Tor 
strains that harbor the classical cholera 
toxin have been associated with spo-
radic outbreaks in the United States 
(5) and, until recently, had not been 
reported anywhere else in the world. 
Then in 2004, hybrid El Tor strains 
that encode the classical cholera toxin 
were isolated from cholera patients in 
Matlab, Bangladesh (6), and in Beira, 
Mozambique (7). In 2006, Nair et al. 
reported that the current seventh pan-
demic prototype El Tor strains had 
been replaced by hybrid El Tor strains 
in Bangladesh (8). We now report 
how far the hybrid El Tor strains have 
spread in Asia and Africa.
We examined 41 clinical V. chol-
erae strains from Asia and Africa that 
were isolated from 1991 through 2004 
(Table) and conﬁ   rmed as serogroup 
O1 by O-antigen biosynthesis gene 
(rfbO1)-speciﬁ  c PCR. Biotyping was 
performed by using standard proce-
dures, and all strains were conﬁ  rmed 
as El Tor (Table). All strains were 
PCR-positive for the El Tor–speciﬁ  c 
451-bp  tcpA and 263-bp rtxC am-
plicons but negative for the classical-
speciﬁ  c 620-bp tcpA amplicon. All 41 
strains were PCR-positive for ctxAB 
(1,037 bp) and produced cholera tox-
in, as demonstrated by the VET-RPLA 
Toxin Detection Kit (Oxoid, Basing-
stoke, UK). Sequence comparison of 
the PCR-ampliﬁ  ed  ctxB gene (460 
bp) of each strain with the reference 
strains (569B and N16961) showed 
that 30 strains harbored classical chol-
era toxin (with histidine at position 
39, phenylalanine at position 46, and 
threonine at position 68), whereas the 
remaining 11 strains carried the El Tor 
cholera toxin gene (with tyrosine at 
position 39, phenylalanine at position 
46, and isoleucine at position 68) (Ta-
ble). The overall analysis showed that 
all test strains are El Tor biotype but 
that most harbor the classical cholera 
toxin gene.
The major ﬁ  nding of this study is 
that El Tor strains that harbor the clas-
sical cholera toxin gene are not limited 
to the US Gulf Coast, Bangladesh, and 
Mozambique; they have spread to sev-
eral other countries in Asia and Africa. 
Since 1817, 7 cholera pandemics have 
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Table. Phenotypic and genotypic traits of Vibrio cholerae O1 clinical strains isolated from Asia and Africa, 1991–2004* 
Phenotypic tests  PCR amplicons  Test strain origin 
(no. examined) or 











Cholera toxin type† 
(no. strains) 
Japan (6)  1991–1997 + + Resistant + + – + Classical (5),  
El Tor (1) 
Hong Kong (18)  1998–2000 + + Resistant + + – + Classical (11),  
El Tor (7) 
Zambia (8)  1996–2004 + + Resistant + + – + Classical (5),  
El Tor (3) 
China (3)  1999 + + Resistant + + – + Classical (3),  
El Tor (0) 
Sri Lanka (1)  1998 + + Resistant + + – + Classical (1),  
El Tor (0) 
Vietnam (5)  1994–2002 + + Resistant + + – + Classical (5),  
El Tor (0) 
Classical 569B   1948 + – Sensitive – – + – Classical 
El Tor N16961   1971 + + Resistant + + – + El Tor 
*rfbO1, O-antigen biosynthesis genes; CCA, chicken cell agglutination; tcp, toxin-coregulated pilus; rtx, repeat in toxin. 
†Based on ctxB sequence. GenBank accession nos. for the ctxB sequences are EU156448–EU156488. LETTERS
occurred around the world. Firm evi-
dence indicates that the ﬁ  fth and sixth 
cholera pandemics were caused by the 
classical biotype whereas the most ex-
tensive and ongoing seventh pandemic 
is caused by the El Tor biotype. Since 
the onset of El Tor dominance in 1961, 
the classical strains have been gradu-
ally replaced by the El Tor strains and 
are now believed to be extinct. How-
ever, reports from Bangladesh (6), 
Mozambique (7), and this study have 
provided sufﬁ  cient evidence to indi-
cate that the classical cholera toxin 
gene has reappeared but that for these 
cases its carrier has been El Tor. Al-
though how the classical cholera toxin 
in El Tor strains would affect V. chol-
erae pathogenicity is unclear, cholera 
caused by the classical biotype is more 
severe, whereas the El Tor biotype is 
considered to be better able to sur-
vive in the environment (1,9). Given 
that cholera toxin is directly respon-
sible for the major clinical sign of the 
disease, such a genetic change could 
result in substantial alteration in the 
clinical manifestation of cholera. Ad-
ditionally, this subtle genetic change 
may also inﬂ  uence the effectiveness of 
current cholera vaccines, which could 
stimulate both antitoxic and antibacte-
rial immunity.
This work was supported by an Area 
of Excellence grant from the University 
Grants Committee of the Hong Kong Spe-
cial Administrative Region, China (project 
AoE/P-04/04).
Ashrafus Safa,* Jinath Sultana,* 
Phung Dac Cam,† 
James C. Mwansa,‡ 
and Richard Y.C. Kong*
*City University of Hong Kong, Hong Kong 
Special Administrative Region, People’s 
Republic of China; †National Institute of Hy-
giene and Epidemiology, Hanoi, Vietnam; 
and ‡University Teaching Hospital, Lusaka, 
Zambia
References
  1.   Kaper JB, Morris JG Jr, Levine MM. Chol-
era. Clin Microbiol Rev. 1995;8:48–86.
  2.   Iredell JR, Manning PA. Biotype-speciﬁ  c 
tcpA genes in Vibrio cholerae. FEMS Mi-
crobiol Lett. 1994;121:47–54.
  3.   Lin W, Fullner KJ, Clayton R, Sexton JA, 
Rogers MB, Calia KE, et al. Identiﬁ  ca-
tion of a Vibrio cholerae RTX toxin gene 
cluster that is tightly linked to the cholera 
toxin prophage. Proc Natl Acad Sci U S A. 
1999;96:1071–6.
  4.   Olsvik Ø, Wahlberg J, Petterson B, Uhlen 
M, Popovic T, Wachsmuth IK, et al. Use 
of automated sequencing of polymerase 
chain reaction–generated amplicons to 
identify three types of cholera toxin sub-
unit B in Vibrio cholerae O1 strains. J Clin 
Microbiol. 1993;31:22–5.
  5.   Blake PA. Endemic cholera in Australia 
and United States. In: Wachsmuth IK, 
Blake PA, Olsvik Ø, editors. Vibrio chol-
erae and cholera: molecular to global per-
spectives. Washington: American Society 
for Microbiology; 1994. p. 309–19.
  6.   Safa A, Bhuyian NA, Nusrin S, Ansaru-
zzaman M, Alam M, Hamabata T, et al. 
Genetic characteristics of Matlab variants 
of Vibrio cholerae O1 that are hybrids be-
tween classical and El Tor biotypes. J Med 
Microbiol. 2006;55:1563–9.
  7.   Ansaruzzaman M, Bhuiyan NA, Nair GB, 
Sack DA, Lucas M, Deen JL, et al. Chol-
era in Mozambique, variant of Vibrio chol-
erae. Emerg Infect Dis. 2004;10:2057–9.
  8.  Nair GB, Qadri F, Holmgren J, Svenner-
holm AM, Safa A, Bhuiyan NA, et al. 
Cholera due to altered El Tor strains of 
Vibrio cholerae O1 in Bangladesh. J Clin 
Microbiol. 2006;44:4211–3.
    9.    Faruque SM, Albert MJ, Mekalanos JJ. 
Epidemiology, genetics, and ecology of 
toxigenic Vibrio cholerae. Microbiol Mol 
Biol Rev. 1998;62:1301–14.
Address for correspondence: Richard Y.C. 
Kong, Department of Biology and Chemistry, 
City University of Hong Kong, 83, Tat Chee 
Ave, Kowloon Tong, Kowloon, Hong Kong 





Infection in 2 Pet 
Dogs, Germany
To the Editor: The genus Myco-
bacterium contains various obligate 
and opportunistic pathogens of ani-
mals, which may also be transmitted 
to humans and cause disease in, thus 
exhibiting a considerable zoonotic 
potential (1,2). During the past few 
decades, members of the Mycobac-
terium avium-intracellulare complex 
(MAIC) emerged as pathogens of hu-
man diseases, including lymphadeni-
tis in children, pulmonary tubercu-
losis-like disease, and disseminated 
infections (occurring predominantly 
in immunocompromised persons, par-
ticularly AIDS patients) (1,2). Simi-
larly, important animal diseases are 
caused by members of this group, e.g., 
avian tuberculosis and paratuberculo-
sis in ruminants (1). MAIC includes 
M. intracellulare and 4 subspecies of 
M. avium, namely, M. avium subsp.
avium, M. avium subsp. hominissuis, 
M. avium subsp. silvaticum, and M. 
avium subsp. paratuberculosis ( 3,4). 
Whereas members of the M. tuber-
culosis complex are transmitted by 
direct host contact, MAIC species are 
acquired predominantly from environ-
mental sources, including soil, water, 
dust, and feed. Subclinical infections 
are common among birds (1,2).
M. avium strains differ from M. 
intracellulare by containing the in-
sertion sequence (IS) IS1245 (3) and 
are further discriminated by terms of 
IS901 ( 4). Avian isolates (M. avium 
subsp. avium) are usually positive for 
IS901 and represent the main pathogen 
of avian tuberculosis (5). In contrast, 
mammalian isolates are IS901-negative 
and have been designated as M. avium 
subsp. hominissuis because of their pre-
dominant hosts. This subspecies is only 
weakly virulent for birds but causes 
disease in animals and humans (5).
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